Company profile
Abvance Therapeutics company profile
Abvance Therapeutics is a biotechnology research company that focuses on innovative solutions to address unmet needs in diabetes care. The company is known for developing a novel coformulation of insulin and glucagon, which could revolutionize diabetes care. This treatment combines two well-understood and FDA-approved peptides to control glycemia while mitigating the threat of hypoglycemia. The company's team of scientists and physicians have discovered this unique approach to diabetes treatment, aiming to reduce hypoglycemia and improve patient outcomes.
Business identity
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00001-00010 employees
- Revenue range
- $1K+
- Founded
- 2016-01-01
Headquarters
- Headquarters
- Homeland, California, United States
- Postal code
- 89511
- Country code
- US
- Continent
- North America